Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited bought 3,577 shares of Rani Therapeutics stock in a transaction that occurred on Wednesday, April 12th. The stock was purchased at an average cost of $5.48 per share, for a total transaction of $19,601.96. Following the purchase, the insider now owns […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited acquired 3,587 shares of the company’s stock in a transaction on Monday, April 3rd. The stock was bought at an average cost of $5.23 per share, with a total value of $18,760.01. Following the completion of the acquisition, the insider now […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited purchased 12,230 shares of Rani Therapeutics stock in a transaction that occurred on Thursday, March 30th. The stock was purchased at an average price of $4.79 per share, with a total value of $58,581.70. Following the completion of the purchase, the […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 268,200 shares, a decrease of 16.2% from the February 28th total of 320,000 shares. Approximately 1.6% of the shares of the company are short sold. Based […]
Talat Imran, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.